Quality of life in patients with allergic asthma on treatment with omalizumab
Background: Omalizumab is a monoclonal antibody that controls severe allergic asthma symptoms and reduces exacerbations. Objective: To analyze quality of life and respiratory function improvement using the mini-AQLQ questionnaire and spirometry, with the use omalizumab as complementary therapy to a...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
2018-09-01
|
| Series: | Revista Alergia México |
| Subjects: | |
| Online Access: | http://revistaalergia.mx/ojs/index.php/ram/article/view/382 |